Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does the FSHB rs10835638 G allele increase FSH levels in women?

The FSHB rs10835638 G allele is associated with higher circulating follicle-stimulating hormone levels in women.

PlausibleJune 19, 20267 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The FSHB rs10835638 G allele is associated with higher follicle-stimulating hormone levels in women.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the G allele at the FSHB promoter variant preserves a high-affinity LHX3 transcription factor binding site, maintaining stronger FSHB transcription and thus higher FSH synthesis. The mechanism graph frames this as a causal chain from the G allele to enhanced promoter activity to increased circulating FSH, which corresponds with observed hormonal and reproductive phenotypes in women.

Verified conclusion

The FSHB gene encodes the beta-subunit of follicle-stimulating hormone (FSH), which dictates the rate-limiting step of functional FSH synthesis. Genetic and molecular evidence robustly demonstrates that the FSHB promoter variant rs10835638 (often designated as c.-211G>T) is a major determinant of circulating FSH levels in women.

Molecular mechanism

  • Transcription factor affinity: The G allele at rs10835638 represents the high-expression wild-type allele. It preserves a high-affinity binding site for LIM homeobox 3 (LHX3), a pituitary-specific transcription factor essential for activating FSHB gene expression.
  • Transcriptional disruption: The alternative T allele introduces a sequence change that disrupts this LHX3 binding motif, impairing transcription. Because FSH beta-subunit synthesis is the rate-limiting step in mature heterodimeric FSH production, carriers of the G allele (particularly those with the GG genotype) maintain stronger transcriptional activation and subsequently release higher levels of circulating FSH into the bloodstream.

Clinical evidence and endocrine outcomes

  • Hormonal phenotype: In premenopausal women, carrying the G allele is strongly associated with higher baseline FSH levels compared to those carrying the T allele.
  • Downstream physiological effects: Large-scale genome-wide association studies (GWAS), including analyses from the UK Biobank, demonstrate that the elevated FSH output linked to the G allele manifests in distinct reproductive phenotypes:
    • Menstrual cycle duration: The G allele is associated with shorter menstrual cycles.
    • Age of menopause: It is genetically linked with an earlier onset of natural menopause.
    • Reproductive conditions: The higher gonadotropin exposure associated with the G allele correlates with an increased risk of developing endometriosis.

Bottom line

The FSHB rs10835638 G allele is strongly associated with higher circulating follicle-stimulating hormone levels in women. Mechanistically, this is because the G allele preserves a high-affinity LHX3 transcription factor binding site in the FSHB promoter, maintaining robust transcriptional activation and hormone synthesis.

References

  1. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men — pmc.ncbi.nlm.nih.gov ↗
  2. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — pmc.ncbi.nlm.nih.gov ↗
  3. Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health — academic.oup.com ↗
  4. Increased Prevalance of the -211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. — academic.oup.com ↗
  5. Pharmacogenetics of follicle-stimulating hormone action — pmc.ncbi.nlm.nih.gov ↗
  6. Molecular regulation of follicle-stimulating hormone synthesis, secretion and action. — pmc.ncbi.nlm.nih.gov ↗
  7. Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→